Alector (ALEC) EPS (Diluted) Growth (1y) (2021 - 2026)
Powered by 
Analysis
Alector (ALEC) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 64.94% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -640.40% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 8.02% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | -4.52% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 89.89% |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 7.59% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 315.14% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -84.85% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 96.41% |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 32.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.03% |
| Mar 31, 2026 | 49.08% |
| Dec 31, 2025 | -128.98% |
| Sep 30, 2025 | 21.95% |
| Jun 30, 2025 | 23.98% |
| Mar 31, 2025 | -5.87% |
| Dec 31, 2024 | 299.00% |
| Sep 30, 2024 | 18.30% |
| Jun 30, 2024 | -2,531.40% |
| Mar 31, 2024 | 30.30% |
| Dec 31, 2023 | 55.02% |
| Sep 30, 2023 | 5.15% |
| Jun 30, 2023 | -86.25% |
| Mar 31, 2023 | -1.54% |
| Dec 31, 2022 | 55.35% |
| Sep 30, 2022 | -137.61% |
| Jun 30, 2022 | 117.31% |
| Mar 31, 2022 | 19.00% |
| Dec 31, 2021 | 12.06% |
| Sep 30, 2021 | 317.68% |